Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749
New York, New York, United States
Medical center in New York City, New York
622 W 168th St, New York, NY 10032
About Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749
NewYork-Presbyterian/Columbia University Irving Medical Center, also known as the Columbia University Irving Medical Center, is an academic medical center and the largest campus of NewYork-Presbyterian Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749
During the past decade, Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749
According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749" are
"Carcinoma, Non-Small-Cell Lung" (1 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749" in a lesser frequency.
Clinical Trials Intervention Types at Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749
Most popular intervention types in "Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Azacitidine" (1 trials), "Bevacizumab" (1 trials), "CPI-444" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749
The vast majority of trials in "Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749" are
2 trials for "All" genders.
Clinical Trials Status at Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749
Currently, there are NaN active trials in "Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".